Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang granules for postoperative non-infectious fever after abdominal surgery
ChiCTR2500100528Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Jingfang Granules in Postoperative fever (POF) (3 arms), sponsored by Second Hospital of Shandong University. Primary endpoint: Body temperature. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Jingfang Granules
03
Conditions
Postoperative fever (POF)
Beyond the preview
Go deeper on ChiCTR2500100528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100528.